Slivka Adam, Gan Ian, Jamidar Priya, Costamagna Guido, Cesaro Paola, Giovannini Marc, Caillol Fabrice, Kahaleh Michel
Division of Gastroenterology, Hepatology & Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Digestive Disease Institute, Gastroenterology and Hepatology Colorectal cancer, Virginia Mason Bellevue Clinic, Seattle, Washington, USA.
Gastrointest Endosc. 2015 Feb;81(2):282-90. doi: 10.1016/j.gie.2014.10.009.
Characterization of indeterminate biliary strictures remains problematic. Tissue sampling is the criterion standard for confirming malignancy but has low sensitivity. Probe-based confocal laser endomicroscopy (pCLE) showed excellent sensitivity in a registry; however, it has not been validated in a prospective study.
To prospectively validate pCLE in real time during ERCP for indeterminate biliary strictures.
Prospective, international, multicenter study.
Six academic centers.
A total of 136 patients with indeterminate biliary strictures.
Investigators provided a presumptive diagnosis based on the patient history, ERCP impression, and pCLE during the procedure before and after tissue sampling results were available. A presumptive diagnosis also was made separately by a blinded investigator during ERCP and after tissue sampling to estimate care without pCLE. Follow-up was at least 6 months.
Accuracy, sensitivity, and specificity during ERCP alone, ERCP with pCLE, and ERCP with pCLE and tissue sampling.
A total of 112 patients were evaluated (71 with malignant lesions). Tissue sampling alone was 56% sensitive, 100% specific, and 72% (95% confidence interval [CI], 63%-80%) accurate. pCLE with ERCP was 89% sensitive, 71% specific, and 82% (95% CI, 74%-89%) accurate. After tissue sampling returned, strictures could be characterized with 88% (95% CI, 81%-94%) accuracy.
No randomization of care maps. pCLE not blinded.
pCLE provided a more accurate and sensitive diagnosis of cholangiocarcinoma compared with tissue sampling alone. Incorporation of pCLE into the diagnostic armamentarium of patients with indeterminate biliary strictures may allow for a more accurate assessment, potentially reducing delays in diagnosis and costly repeat testing. (
NCT01392274.).
不确定的胆管狭窄的特征描述仍然存在问题。组织采样是确认恶性肿瘤的标准方法,但敏感性较低。基于探头的共聚焦激光内镜检查(pCLE)在一项登记研究中显示出极佳的敏感性;然而,它尚未在前瞻性研究中得到验证。
在ERCP期间对不确定的胆管狭窄进行实时前瞻性验证pCLE。
前瞻性、国际性、多中心研究。
六个学术中心。
总共136例不确定胆管狭窄患者。
在组织采样结果出来之前和之后,研究人员在手术过程中根据患者病史、ERCP印象和pCLE提供初步诊断。一名不知情的研究人员在ERCP期间和组织采样后也分别做出初步诊断,以评估无pCLE时的诊疗情况。随访至少6个月。
单独ERCP、ERCP联合pCLE以及ERCP联合pCLE和组织采样时的准确性、敏感性和特异性。
共评估了112例患者(71例有恶性病变)。单独组织采样的敏感性为56%,特异性为100%,准确性为72%(95%置信区间[CI],63%-80%)。ERCP联合pCLE的敏感性为89%,特异性为71%,准确性为82%(95%CI,74%-89%)。组织采样结果出来后,狭窄的特征描述准确性为88%(95%CI,81%-94%)。
诊疗方案未随机化。pCLE未设盲。
与单独组织采样相比,pCLE对胆管癌的诊断更准确、更敏感。将pCLE纳入不确定胆管狭窄患者的诊断手段中,可能会实现更准确的评估,潜在地减少诊断延迟和昂贵的重复检查。(临床试验注册号:NCT01392274。)